VANGUARD GROUP INC 13D and 13G filings for Inovio Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-30 9:58 pm Purchase | 2024-12-31 | 13G | Inovio Pharmaceuticals, Inc. INO | VANGUARD GROUP INC | 1,673,587 4.640% | 1,673,587 (New Position) | Filing |